APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pathology Image Analysis System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Pathology Image Analysis System Market Analysis and Forecast 2026-2032

12 August 2026182 pages

Choose your research edition.

Industry ResearchAI Pathology Image Analysis System Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pathology Image Analysis System Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal AI Pathology Image Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pathology Image Analysis System Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pathology Image Analysis System Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

The global AI Pathology Image Analysis System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Pathology Image Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Pathology Image Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Pathology Image Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Pathology Image Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Pathology Image Analysis System include Roche, Proscia, Indica Labs, Visiopharm, Aiforia, Lunit, Deep Bio, Mindpeak and Techcyte, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Pathology Image Analysis System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Pathology Image Analysis System, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Pathology Image Analysis System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Pathology Image Analysis System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Pathology Image Analysis System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Pathology Image Analysis System revenue, projected growth trends, production technology, application and end-user industry.

AI Pathology Image Analysis System Segment by Company

Roche

Proscia

Indica Labs

Visiopharm

Aiforia

Lunit

Deep Bio

Mindpeak

Techcyte

Qritive

Deciphex

Owkin

Aiosyn

DoMore Diagnostics

Stratipath

AIRA Matrix

Tribun Health

PathAI

Paige

Ibex Medical Analytics

AI Pathology Image Analysis System Segment by Type

Task-Specific AI Algorithms

Modular Image Analysis Suites

End-to-End AI Pathology Platforms

AI Model Development Platforms

AI-Enabled Image Management Systems

AI Pathology Image Analysis System Segment by Application

Cancer Diagnosis and Grading

Biomarker Scoring and Companion Diagnostics

Prognosis and Treatment Selection

Drug Discovery and Clinical Trials

Preclinical Safety Assessment

Pathology Workflow and Quality Control

AI Pathology Image Analysis System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Image Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Image Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Image Analysis System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Pathology Image Analysis System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Pathology Image Analysis System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pathology Image Analysis System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Pathology Image Analysis System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Task-Specific AI Algorithms Major Player Table 3. Modular Image Analysis Suites Major Player Table 4. End-to-End AI Pathology Platforms Major Player Table 5. AI Model Development Platforms Major Player Table 6. AI-Enabled Image Management Systems Major Player Table 7. Global AI Pathology Image Analysis System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Cancer Diagnosis and Grading Major Player Table 9. Biomarker Scoring and Companion Diagnostics Major Player Table 10. Prognosis and Treatment Selection Major Player Table 11. Drug Discovery and Clinical Trials Major Player Table 12. Preclinical Safety Assessment Major Player Table 13. Pathology Workflow and Quality Control Major Player Table 14. AI Pathology Image Analysis System Industry Trends Table 15. AI Pathology Image Analysis System Industry Drivers Table 16. AI Pathology Image Analysis System Industry Opportunities and Challenges Table 17. AI Pathology Image Analysis System Industry Restraints Table 18. Global AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global AI Pathology Image Analysis System Market Size by Region (2021-2026) & (US$ Million) Table 20. Global AI Pathology Image Analysis System Market Share by Region (2021-2026) Table 21. Global AI Pathology Image Analysis System Market Size by Region (2027-2032) & (US$ Million) Table 22. Global AI Pathology Image Analysis System Market Share by Region (2027-2032) Table 23. Global AI Pathology Image Analysis System Revenue by Players (US$ Million) & (2021-2026) Table 24. Global AI Pathology Image Analysis System Revenue Market Share by Players (2021-2026) Table 25. Global AI Pathology Image Analysis System Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global AI Pathology Image Analysis System Key Players Headquarters & Area Served Table 27. Global AI Pathology Image Analysis System Players, Product Type & Application Table 28. Global AI Pathology Image Analysis System Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global AI Pathology Image Analysis System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global AI Pathology Image Analysis System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 33. Global AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 34. Global AI Pathology Image Analysis System Revenue Market Share by Type (2021-2026) Table 35. Global AI Pathology Image Analysis System Revenue Market Share by Type (2027-2032) Table 36. Global AI Pathology Image Analysis System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 38. Global AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 39. Global AI Pathology Image Analysis System Revenue Market Share by Application (2021-2026) Table 40. Global AI Pathology Image Analysis System Revenue Market Share by Application (2027-2032) Table 41. Roche Company Information Table 42. Roche Business Overview Table 43. Roche AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Roche AI Pathology Image Analysis System Product Portfolio Table 45. Roche Recent Development Table 46. Proscia Company Information Table 47. Proscia Business Overview Table 48. Proscia AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Proscia AI Pathology Image Analysis System Product Portfolio Table 50. Proscia Recent Development Table 51. Indica Labs Company Information Table 52. Indica Labs Business Overview Table 53. Indica Labs AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Indica Labs AI Pathology Image Analysis System Product Portfolio Table 55. Indica Labs Recent Development Table 56. Visiopharm Company Information Table 57. Visiopharm Business Overview Table 58. Visiopharm AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Visiopharm AI Pathology Image Analysis System Product Portfolio Table 60. Visiopharm Recent Development Table 61. Aiforia Company Information Table 62. Aiforia Business Overview Table 63. Aiforia AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Aiforia AI Pathology Image Analysis System Product Portfolio Table 65. Aiforia Recent Development Table 66. Lunit Company Information Table 67. Lunit Business Overview Table 68. Lunit AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Lunit AI Pathology Image Analysis System Product Portfolio Table 70. Lunit Recent Development Table 71. Deep Bio Company Information Table 72. Deep Bio Business Overview Table 73. Deep Bio AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Deep Bio AI Pathology Image Analysis System Product Portfolio Table 75. Deep Bio Recent Development Table 76. Mindpeak Company Information Table 77. Mindpeak Business Overview Table 78. Mindpeak AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Mindpeak AI Pathology Image Analysis System Product Portfolio Table 80. Mindpeak Recent Development Table 81. Techcyte Company Information Table 82. Techcyte Business Overview Table 83. Techcyte AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Techcyte AI Pathology Image Analysis System Product Portfolio Table 85. Techcyte Recent Development Table 86. Qritive Company Information Table 87. Qritive Business Overview Table 88. Qritive AI Pathology Image Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Qritive AI Pathology Image Analysis System Product Portfolio Table 90. Qritive Recent Development Table 91. Deciphex Company Information Table 92. Deciphex Business Overview Table 93. Deciphex AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Deciphex AI Pathology Image Analysis System Product Portfolio Table 95. Deciphex Recent Development Table 96. Owkin Company Information Table 97. Owkin Business Overview Table 98. Owkin AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Owkin AI Pathology Image Analysis System Product Portfolio Table 100. Owkin Recent Development Table 101. Aiosyn Company Information Table 102. Aiosyn Business Overview Table 103. Aiosyn AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Aiosyn AI Pathology Image Analysis System Product Portfolio Table 105. Aiosyn Recent Development Table 106. DoMore Diagnostics Company Information Table 107. DoMore Diagnostics Business Overview Table 108. DoMore Diagnostics AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. DoMore Diagnostics AI Pathology Image Analysis System Product Portfolio Table 110. DoMore Diagnostics Recent Development Table 111. Stratipath Company Information Table 112. Stratipath Business Overview Table 113. Stratipath AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Stratipath AI Pathology Image Analysis System Product Portfolio Table 115. Stratipath Recent Development Table 116. AIRA Matrix Company Information Table 117. AIRA Matrix Business Overview Table 118. AIRA Matrix AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. AIRA Matrix AI Pathology Image Analysis System Product Portfolio Table 120. AIRA Matrix Recent Development Table 121. Tribun Health Company Information Table 122. Tribun Health Business Overview Table 123. Tribun Health AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Tribun Health AI Pathology Image Analysis System Product Portfolio Table 125. Tribun Health Recent Development Table 126. PathAI Company Information Table 127. PathAI Business Overview Table 128. PathAI AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. PathAI AI Pathology Image Analysis System Product Portfolio Table 130. PathAI Recent Development Table 131. Paige Company Information Table 132. Paige Business Overview Table 133. Paige AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Paige AI Pathology Image Analysis System Product Portfolio Table 135. Paige Recent Development Table 136. Ibex Medical Analytics Company Information Table 137. Ibex Medical Analytics Business Overview Table 138. Ibex Medical Analytics AI Pathology Image Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Ibex Medical Analytics AI Pathology Image Analysis System Product Portfolio Table 140. Ibex Medical Analytics Recent Development Table 141. North America AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 142. North America AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 143. North America AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 144. North America AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 145. North America AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America AI Pathology Image Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 147. North America AI Pathology Image Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 148. Europe AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe AI Pathology Image Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 154. Europe AI Pathology Image Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 155. China AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 156. China AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 157. China AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 158. China AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 162. Asia AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 163. Asia AI Pathology Image Analysis System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia AI Pathology Image Analysis System Revenue by Region (US$ Million) & (2021-2026) Table 165. Asia AI Pathology Image Analysis System Revenue by Region (US$ Million) & (2027-2032) Table 166. SAMEA AI Pathology Image Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 167. SAMEA AI Pathology Image Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 168. SAMEA AI Pathology Image Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA AI Pathology Image Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA AI Pathology Image Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 172. SAMEA AI Pathology Image Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. AI Pathology Image Analysis System Image Figure 2. Global AI Pathology Image Analysis System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Pathology Image Analysis System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Task-Specific AI Algorithms Image Figure 5. Modular Image Analysis Suites Image Figure 6. End-to-End AI Pathology Platforms Image Figure 7. AI Model Development Platforms Image Figure 8. AI-Enabled Image Management Systems Image Figure 9. Global AI Pathology Image Analysis System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global AI Pathology Image Analysis System Market Size Share 2021 VS 2025 VS 2032 Figure 11. Cancer Diagnosis and Grading Image Figure 12. Biomarker Scoring and Companion Diagnostics Image Figure 13. Prognosis and Treatment Selection Image Figure 14. Drug Discovery and Clinical Trials Image Figure 15. Preclinical Safety Assessment Image Figure 16. Pathology Workflow and Quality Control Image Figure 17. Global AI Pathology Image Analysis System Market Size (US$ Million) & (2021-2032) Figure 18. Global AI Pathology Image Analysis System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global AI Pathology Image Analysis System Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global AI Pathology Image Analysis System Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global AI Pathology Image Analysis System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI Pathology Image Analysis System Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global AI Pathology Image Analysis System Revenue Market Share by Type (2021-2032) Figure 25. Global AI Pathology Image Analysis System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global AI Pathology Image Analysis System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global AI Pathology Image Analysis System Revenue Market Share by Application (2021-2032) Figure 28. North America AI Pathology Image Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America AI Pathology Image Analysis System Revenue Share by Type (2021-2032) Figure 30. North America AI Pathology Image Analysis System Revenue Share by Application (2021-2032) Figure 31. North America AI Pathology Image Analysis System Revenue Share by Country (2021-2032) Figure 32. United States AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe AI Pathology Image Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe AI Pathology Image Analysis System Revenue Share by Type (2021-2032) Figure 37. Europe AI Pathology Image Analysis System Revenue Share by Application (2021-2032) Figure 38. Europe AI Pathology Image Analysis System Revenue Share by Country (2021-2032) Figure 39. Germany AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China AI Pathology Image Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China AI Pathology Image Analysis System Revenue Share by Type (2021-2032) Figure 49. China AI Pathology Image Analysis System Revenue Share by Application (2021-2032) Figure 50. Asia AI Pathology Image Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia AI Pathology Image Analysis System Revenue Share by Type (2021-2032) Figure 52. Asia AI Pathology Image Analysis System Revenue Share by Application (2021-2032) Figure 53. Asia AI Pathology Image Analysis System Revenue Share by Region (2021-2032) Figure 54. Japan AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA AI Pathology Image Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA AI Pathology Image Analysis System Revenue Share by Type (2021-2032) Figure 62. SAMEA AI Pathology Image Analysis System Revenue Share by Application (2021-2032) Figure 63. SAMEA AI Pathology Image Analysis System Revenue Share by Country (2021-2032) Figure 64. Brazil AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt AI Pathology Image Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Task-Specific AI Algorithms
  • Modular Image Analysis Suites
  • End-to-End AI Pathology Platforms
  • AI Model Development Platforms
  • AI-Enabled Image Management Systems
Applications
  • Cancer Diagnosis and Grading
  • Biomarker Scoring and Companion Diagnostics
  • Prognosis and Treatment Selection
  • Drug Discovery and Clinical Trials
  • Preclinical Safety Assessment
  • Pathology Workflow and Quality Control
Companies covered
  • Roche
  • Proscia
  • Indica Labs
  • Visiopharm
  • Aiforia
  • Lunit
  • Deep Bio
  • Mindpeak
  • Techcyte
  • Qritive
  • Deciphex
  • Owkin
  • Aiosyn
  • DoMore Diagnostics
  • Stratipath
  • AIRA Matrix
  • Tribun Health
  • PathAI
  • Paige
  • Ibex Medical Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Pathology Image Analysis System Market by Type
  3. 1.2.1 Global AI Pathology Image Analysis System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Task-Specific AI Algorithms
  5. 1.2.3 Modular Image Analysis Suites
  6. 1.2.4 End-to-End AI Pathology Platforms
  7. 1.2.5 AI Model Development Platforms
  8. 1.2.6 AI-Enabled Image Management Systems
  9. 1.3 AI Pathology Image Analysis System Market by Application
  10. 1.3.1 Global AI Pathology Image Analysis System Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Cancer Diagnosis and Grading
  12. 1.3.3 Biomarker Scoring and Companion Diagnostics
  13. 1.3.4 Prognosis and Treatment Selection
  14. 1.3.5 Drug Discovery and Clinical Trials
  15. 1.3.6 Preclinical Safety Assessment
  16. 1.3.7 Pathology Workflow and Quality Control
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 AI Pathology Image Analysis System Market Dynamics
  1. 2.1 AI Pathology Image Analysis System Industry Trends
  2. 2.2 AI Pathology Image Analysis System Industry Drivers
  3. 2.3 AI Pathology Image Analysis System Industry Opportunities and Challenges
  4. 2.4 AI Pathology Image Analysis System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Pathology Image Analysis System Market Perspective (2021-2032)
  2. 3.2 Global AI Pathology Image Analysis System Growth Trends by Region
  3. 3.2.1 Global AI Pathology Image Analysis System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Pathology Image Analysis System Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Pathology Image Analysis System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Pathology Image Analysis System Revenue by Players
  2. 4.1.1 Global AI Pathology Image Analysis System Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Pathology Image Analysis System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Pathology Image Analysis System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Pathology Image Analysis System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Pathology Image Analysis System Key Players Headquarters & Area Served
  7. 4.4 Global AI Pathology Image Analysis System Players, Product Type & Application
  8. 4.5 Global AI Pathology Image Analysis System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Pathology Image Analysis System Market CR5 and HHI
  11. 4.6.3 2025 AI Pathology Image Analysis System Tier 1, Tier 2, and Tier 3
5 AI Pathology Image Analysis System Market Size by Type
  1. 5.1 Global AI Pathology Image Analysis System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 5.3 Global AI Pathology Image Analysis System Revenue Market Share by Type (2021-2032)
6 AI Pathology Image Analysis System Market Size by Application
  1. 6.1 Global AI Pathology Image Analysis System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Pathology Image Analysis System Revenue by Application (2021-2032)
  3. 6.3 Global AI Pathology Image Analysis System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche AI Pathology Image Analysis System Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Proscia
  8. 7.2.1 Proscia Company Information
  9. 7.2.2 Proscia Business Overview
  10. 7.2.3 Proscia AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Proscia AI Pathology Image Analysis System Product Portfolio
  12. 7.2.5 Proscia Recent Developments
  13. 7.3 Indica Labs
  14. 7.3.1 Indica Labs Company Information
  15. 7.3.2 Indica Labs Business Overview
  16. 7.3.3 Indica Labs AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Indica Labs AI Pathology Image Analysis System Product Portfolio
  18. 7.3.5 Indica Labs Recent Developments
  19. 7.4 Visiopharm
  20. 7.4.1 Visiopharm Company Information
  21. 7.4.2 Visiopharm Business Overview
  22. 7.4.3 Visiopharm AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Visiopharm AI Pathology Image Analysis System Product Portfolio
  24. 7.4.5 Visiopharm Recent Developments
  25. 7.5 Aiforia
  26. 7.5.1 Aiforia Company Information
  27. 7.5.2 Aiforia Business Overview
  28. 7.5.3 Aiforia AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Aiforia AI Pathology Image Analysis System Product Portfolio
  30. 7.5.5 Aiforia Recent Developments
  31. 7.6 Lunit
  32. 7.6.1 Lunit Company Information
  33. 7.6.2 Lunit Business Overview
  34. 7.6.3 Lunit AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Lunit AI Pathology Image Analysis System Product Portfolio
  36. 7.6.5 Lunit Recent Developments
  37. 7.7 Deep Bio
  38. 7.7.1 Deep Bio Company Information
  39. 7.7.2 Deep Bio Business Overview
  40. 7.7.3 Deep Bio AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Deep Bio AI Pathology Image Analysis System Product Portfolio
  42. 7.7.5 Deep Bio Recent Developments
  43. 7.8 Mindpeak
  44. 7.8.1 Mindpeak Company Information
  45. 7.8.2 Mindpeak Business Overview
  46. 7.8.3 Mindpeak AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Mindpeak AI Pathology Image Analysis System Product Portfolio
  48. 7.8.5 Mindpeak Recent Developments
  49. 7.9 Techcyte
  50. 7.9.1 Techcyte Company Information
  51. 7.9.2 Techcyte Business Overview
  52. 7.9.3 Techcyte AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Techcyte AI Pathology Image Analysis System Product Portfolio
  54. 7.9.5 Techcyte Recent Developments
  55. 7.10 Qritive
  56. 7.10.1 Qritive Company Information
  57. 7.10.2 Qritive Business Overview
  58. 7.10.3 Qritive AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Qritive AI Pathology Image Analysis System Product Portfolio
  60. 7.10.5 Qritive Recent Developments
  61. 7.11 Deciphex
  62. 7.11.1 Deciphex Company Information
  63. 7.11.2 Deciphex Business Overview
  64. 7.11.3 Deciphex AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Deciphex AI Pathology Image Analysis System Product Portfolio
  66. 7.11.5 Deciphex Recent Developments
  67. 7.12 Owkin
  68. 7.12.1 Owkin Company Information
  69. 7.12.2 Owkin Business Overview
  70. 7.12.3 Owkin AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Owkin AI Pathology Image Analysis System Product Portfolio
  72. 7.12.5 Owkin Recent Developments
  73. 7.13 Aiosyn
  74. 7.13.1 Aiosyn Company Information
  75. 7.13.2 Aiosyn Business Overview
  76. 7.13.3 Aiosyn AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Aiosyn AI Pathology Image Analysis System Product Portfolio
  78. 7.13.5 Aiosyn Recent Developments
  79. 7.14 DoMore Diagnostics
  80. 7.14.1 DoMore Diagnostics Company Information
  81. 7.14.2 DoMore Diagnostics Business Overview
  82. 7.14.3 DoMore Diagnostics AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 DoMore Diagnostics AI Pathology Image Analysis System Product Portfolio
  84. 7.14.5 DoMore Diagnostics Recent Developments
  85. 7.15 Stratipath
  86. 7.15.1 Stratipath Company Information
  87. 7.15.2 Stratipath Business Overview
  88. 7.15.3 Stratipath AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Stratipath AI Pathology Image Analysis System Product Portfolio
  90. 7.15.5 Stratipath Recent Developments
  91. 7.16 AIRA Matrix
  92. 7.16.1 AIRA Matrix Company Information
  93. 7.16.2 AIRA Matrix Business Overview
  94. 7.16.3 AIRA Matrix AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  95. 7.16.4 AIRA Matrix AI Pathology Image Analysis System Product Portfolio
  96. 7.16.5 AIRA Matrix Recent Developments
  97. 7.17 Tribun Health
  98. 7.17.1 Tribun Health Company Information
  99. 7.17.2 Tribun Health Business Overview
  100. 7.17.3 Tribun Health AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Tribun Health AI Pathology Image Analysis System Product Portfolio
  102. 7.17.5 Tribun Health Recent Developments
  103. 7.18 PathAI
  104. 7.18.1 PathAI Company Information
  105. 7.18.2 PathAI Business Overview
  106. 7.18.3 PathAI AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  107. 7.18.4 PathAI AI Pathology Image Analysis System Product Portfolio
  108. 7.18.5 PathAI Recent Developments
  109. 7.19 Paige
  110. 7.19.1 Paige Company Information
  111. 7.19.2 Paige Business Overview
  112. 7.19.3 Paige AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Paige AI Pathology Image Analysis System Product Portfolio
  114. 7.19.5 Paige Recent Developments
  115. 7.20 Ibex Medical Analytics
  116. 7.20.1 Ibex Medical Analytics Company Information
  117. 7.20.2 Ibex Medical Analytics Business Overview
  118. 7.20.3 Ibex Medical Analytics AI Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Ibex Medical Analytics AI Pathology Image Analysis System Product Portfolio
  120. 7.20.5 Ibex Medical Analytics Recent Developments
8 North America
  1. 8.1 North America AI Pathology Image Analysis System Revenue (2021-2032)
  2. 8.2 North America AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Pathology Image Analysis System Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Pathology Image Analysis System Revenue by Type (2027-2032)
  5. 8.3 North America AI Pathology Image Analysis System Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Pathology Image Analysis System Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Pathology Image Analysis System Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Pathology Image Analysis System Revenue by Application (2027-2032)
  9. 8.5 North America AI Pathology Image Analysis System Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Pathology Image Analysis System Revenue by Country
  11. 8.6.1 North America AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Pathology Image Analysis System Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Pathology Image Analysis System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Pathology Image Analysis System Revenue (2021-2032)
  2. 9.2 Europe AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Pathology Image Analysis System Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Pathology Image Analysis System Revenue by Type (2027-2032)
  5. 9.3 Europe AI Pathology Image Analysis System Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Pathology Image Analysis System Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Pathology Image Analysis System Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Pathology Image Analysis System Revenue by Application (2027-2032)
  9. 9.5 Europe AI Pathology Image Analysis System Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Pathology Image Analysis System Revenue by Country
  11. 9.6.1 Europe AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Pathology Image Analysis System Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Pathology Image Analysis System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Pathology Image Analysis System Revenue (2021-2032)
  2. 10.2 China AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 10.2.1 China AI Pathology Image Analysis System Revenue by Type (2021-2026)
  4. 10.2.2 China AI Pathology Image Analysis System Revenue by Type (2027-2032)
  5. 10.3 China AI Pathology Image Analysis System Revenue Share by Type (2021-2032)
  6. 10.4 China AI Pathology Image Analysis System Revenue by Application (2021-2032)
  7. 10.4.1 China AI Pathology Image Analysis System Revenue by Application (2021-2026)
  8. 10.4.2 China AI Pathology Image Analysis System Revenue by Application (2027-2032)
  9. 10.5 China AI Pathology Image Analysis System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Pathology Image Analysis System Revenue (2021-2032)
  2. 11.2 Asia AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Pathology Image Analysis System Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Pathology Image Analysis System Revenue by Type (2027-2032)
  5. 11.3 Asia AI Pathology Image Analysis System Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Pathology Image Analysis System Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Pathology Image Analysis System Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Pathology Image Analysis System Revenue by Application (2027-2032)
  9. 11.5 Asia AI Pathology Image Analysis System Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Pathology Image Analysis System Revenue by Country
  11. 11.6.1 Asia AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Pathology Image Analysis System Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Pathology Image Analysis System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Pathology Image Analysis System Revenue (2021-2032)
  2. 12.2 SAMEA AI Pathology Image Analysis System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Pathology Image Analysis System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Pathology Image Analysis System Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Pathology Image Analysis System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Pathology Image Analysis System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Pathology Image Analysis System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Pathology Image Analysis System Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Pathology Image Analysis System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Pathology Image Analysis System Revenue by Country
  11. 12.6.1 SAMEA AI Pathology Image Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Pathology Image Analysis System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Pathology Image Analysis System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst